openPR Logo
Press release

Anticancer Drugs Market to Hit USD 495.07 Bn by 2030, Growing at 12.1% CAGR

Anticancer Drugs Market

Anticancer Drugs Market

๐€๐ง๐ญ๐ข๐œ๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐จ๐ข๐ฌ๐ž๐ ๐Ÿ๐จ๐ซ ๐’๐ข๐ ๐ง๐ข๐Ÿ๐ข๐œ๐š๐ง๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก

The global anticancer drugs market is experiencing substantial expansion, with its size valued at USD 222.57 billion in 2023 and projected to reach USD 495.07 billion by 2030, reflecting a compound annual growth rate (CAGR) of 12.1%.

This growth is driven by the increasing prevalence of cancer worldwide, advancements in drug development, and supportive regulatory environments facilitating the swift approval of new therapies.

๐†๐ซ๐š๐› ๐ฒ๐จ๐ฎ๐ซ ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ญ๐จ๐๐š๐ฒ: https://www.maximizemarketresearch.com/request-sample/37133/

๐€๐ง๐ญ๐ข๐œ๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐š๐ง๐ ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ž ๐”๐ง๐ข๐ญ๐ž๐ ๐’๐ญ๐š๐ญ๐ž๐ฌ:

In the United States, the oncology drugs market was valued at USD 150.2 billion in 2023 and is expected to grow at a CAGR of 15.51%, reaching nearly USD 412.2 billion by 2030.

This robust growth is attributed to advancements in cancer treatment and a high prevalence of cancer cases. Notably, ๐๐Ÿ๐ข๐ณ๐ž๐ซ's $43 billion acquisition of biotech company ๐’๐ž๐š๐ ๐ž๐ง underscores the trend toward consolidation, aiming to enhance its oncology portfolio with next-generation cancer therapies.

๐€๐ง๐ญ๐ข๐œ๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐‚๐ก๐ข๐ง๐š:

China is witnessing a significant increase in demand for anticancer drugs, driven by a rising incidence of cancer and efforts to improve healthcare infrastructure. The focus on early detection and treatment accessibility presents substantial market opportunities. However, challenges such as balancing economic sustainability with access to new treatments remain, as highlighted by the projected global increase in spending on oncology therapies.

๐€๐ง๐ญ๐ข๐œ๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ ๐š๐ง๐ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐„๐ฎ๐ซ๐จ๐ฉ๐ž:

Europe continues to be a significant player in the anticancer drugs market, with ongoing investments in research and development leading to innovative therapies. The region faces challenges related to the high cost of advanced biotherapies, necessitating strategies to balance economic sustainability and patient access to cutting-edge treatments.

๐€๐ง๐ญ๐ข๐œ๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐š๐ง๐ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ž ๐‰๐š๐ฉ๐š๐ง:

Japan's anticancer drugs market is expanding due to an aging population and increased cancer prevalence. The country is investing in innovative treatments, including immunotherapies and targeted therapies, to improve patient outcomes. Collaborations between domestic and international pharmaceutical companies are fostering the development and availability of new anticancer drugs.

๐€๐ง๐ญ๐ข๐œ๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š:

South Korea is experiencing growth in its anticancer drugs market, supported by government initiatives to enhance cancer care and substantial investments in biotechnology. The country's focus on research and development is leading to the introduction of novel therapies, presenting opportunities for both local and global pharmaceutical companies.

๐€๐ง๐ญ๐ข๐œ๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐’๐ข๐ง๐ ๐š๐ฉ๐จ๐ซ๐ž:

Singapore's strategic investments in healthcare infrastructure and emphasis on medical research are propelling the growth of its anticancer drugs market. The nation's commitment to becoming a biomedical hub in Asia is attracting pharmaceutical companies to establish research and development centers, fostering innovation in cancer treatment.

๐€๐ง๐ญ๐ข๐œ๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ง ๐•๐ข๐ž๐ญ๐ง๐š๐ฆ ๐š๐ง๐ ๐“๐ก๐š๐ข๐ฅ๐š๐ง๐:

Vietnam and Thailand are emerging markets in the anticancer drugs industry, with increasing cancer incidence rates and efforts to improve healthcare services. These countries are focusing on enhancing access to cancer treatments and are potential markets for pharmaceutical companies looking to expand in Southeast Asia.

๐‚๐ฎ๐ซ๐ข๐จ๐ฎ๐ฌ ๐ญ๐จ ๐ฉ๐ž๐ž๐ค ๐ข๐ง๐ฌ๐ข๐๐ž? ๐†๐ซ๐š๐› ๐ฒ๐จ๐ฎ๐ซ ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ง๐จ๐ฐ: https://www.maximizemarketresearch.com/request-sample/37133/

๐€๐ง๐ญ๐ข๐œ๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

๐‘ฉ๐’š ๐‘ซ๐’“๐’–๐’ˆ ๐‘ป๐’š๐’‘๐’†

Cytotoxic Drugs
Alkylating Agents
Antimetabolites
Others
Targeted Drugs
Monoclonal Antibodies
Tyrosine Kinase Inhibitors
Others
Hormonal Drugs
Others

๐‘ฉ๐’š ๐‘ป๐’‰๐’†๐’“๐’‚๐’‘๐’š ๐‘ป๐’š๐’‘๐’†

Chemotherapy
Targeted Therapy
Immunotherapy
Others

๐‘ฉ๐’š ๐‘ช๐’‚๐’๐’„๐’†๐’“ ๐‘ป๐’š๐’‘๐’†

Breast Cancer
Lung Cancer
Stomach Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Others

๐‘ฉ๐’š ๐‘ซ๐’Š๐’”๐’•๐’“๐’Š๐’ƒ๐’–๐’•๐’Š๐’๐’ ๐‘ช๐’‰๐’‚๐’๐’๐’†๐’

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Breast cancer, lung cancer, stomach cancer, colorectal cancer, prostate cancer, liver cancer, and others are the many cancer types into which the market is divided. Over the course of the projection period, breast cancer is anticipated to dominate the market for anticancer drugs. The World Health Organisation (WHO) launched the Global Breast Cancer Initiative in response to the widespread impact of breast cancer. The initiative aims to prevent millions of deaths by 2040 by reducing the global breast cancer mortality rate by 2.5% yearly. A thorough approach to managing breast cancer, prompt diagnosis, and health promotion for early detection are the initiative's main tenets. A key component of accomplishing these goals is public education, which is supported by training for health workers and the creation of trustworthy referral channels.

๐“๐จ ๐Ÿ๐ข๐ง๐ ๐ฆ๐จ๐ซ๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐š๐›๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก, ๐ฉ๐ฅ๐ž๐š๐ฌ๐ž ๐ฏ๐ข๐ฌ๐ข๐ญ: https://www.maximizemarketresearch.com/request-sample/37133/

๐€๐ง๐ญ๐ข๐œ๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

Global
1. Roche (F. Hoffmann-La Roche Ltd) (Basel, Switzerland)
2. Novartis (Basel, Switzerland)
3. Pfizer (New York City, New York, USA)
4. Merck & Co., Inc. (Merck Sharp & Dohme Corp.) (Kenilworth, New Jersey, USA)
5. Bristol Myers Squibb (New York City, New York, USA)

North America
1. Eli Lilly and Company (Indianapolis, Indiana, USA)
2. Johnson & Johnson (New Brunswick, New Jersey, USA)
3. Celgene Corporation (Summit, New Jersey, USA)
4. Gilead Sciences (Foster City, California, USA)
5. Amgen (Thousand Oaks, California, USA)
6. Incyte Corporation (Wilmington, Delaware, USA)

Europe
1. AstraZeneca (Cambridge, United Kingdom)
2. Sanofi (Paris, France)
3. Merck KGaA (Darmstadt, Germany)
4. Ipsen (Paris, France)

Asia Pacific
1. Takeda Pharmaceutical Company Limited (Tokyo, Japan)
2. Eisai Co., Ltd. (Tokyo, Japan
3. Astellas Pharma Inc. (Tokyo, Japan)
4. Daiichi Sankyo Company, Limited (Tokyo, Japan)
5. Kyowa Kirin Co., Ltd. (Tokyo, Japan)
6. Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan)
7. Shionogi & Co., Ltd. (Osaka, Japan)
8. Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan)

๐•๐ข๐ž๐ฐ ๐๐จ๐ฉ๐ฎ๐ฅ๐š๐ซ ๐“๐จ๐ฉ๐ข๐œ๐ฌ ๐๐จ๐ฐ:

Latin America Ventilator Market https://www.maximizemarketresearch.com/market-report/ventilator-market-latin-america/1970/

Global Band Ligators Market https://www.maximizemarketresearch.com/market-report/global-band-ligators-market/87188/

Malaysia Electric Vehicle Market https://www.maximizemarketresearch.com/market-report/malaysia-electric-vehicle-market/65822/

Kinetic Tiles Market https://www.maximizemarketresearch.com/market-report/kinetic-tiles-market/184256/

Cured-In-Place Pipe Consumption Market https://www.maximizemarketresearch.com/market-report/cured-in-place-pipe-consumption-market/194745/

Pedestrian Bridge Market https://www.maximizemarketresearch.com/market-report/pedestrian-bridge-market/194746/

Tile Adhesives and Stone Adhesives Market https://www.maximizemarketresearch.com/market-report/tile-adhesives-and-stone-adhesives-market/158274/

Europe Functional Cosmetics Market https://www.maximizemarketresearch.com/market-report/europe-functional-cosmetics-market/126144/

Global Health Care Social Media Marketing Market https://www.maximizemarketresearch.com/market-report/global-health-care-social-media-marketing-market/99853/

BRICS Diabetes Drugs Market https://www.maximizemarketresearch.com/market-report/brics-diabetes-drugs-market/356/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticancer Drugs Market to Hit USD 495.07 Bn by 2030, Growing at 12.1% CAGR here

News-ID: 3823897 • Views: โ€ฆ

More Releases from Maximize Market Research Pvt. Ltd.

Ready-to-Drink Beverages Market Size to Reach USD 1,227.81 Billion by 2032
Ready-to-Drink Beverages Market Size to Reach USD 1,227.81 Billion by 2032
Ready-to-Drink Beverages Market is poised for substantial growth over the forecast period, driven by changing consumer lifestyles, rising disposable income, expanding urbanization, and increasing demand for convenient beverage solutions. According to recent industry analysis, the global Ready-to-Drink Beverages Market was valued at USD 766.69 Billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.22% from 2025 to 2032, reaching nearly USD 1,227.81 Billionโ€ฆ
Second hand Product Market Set to Surpass USD 1451.34 Billion by 2032, Expanding at a Robust 13.6% CAGR
Second hand Product Market Set to Surpass USD 1451.34 Billion by 2032, Expanding โ€ฆ
Second hand Product Market was valued at USD 594.45 Billion in 2025 and is projected to grow at a robust CAGR of 13.6% from 2025 to 2032, reaching nearly USD 1451.34 Billion by 2032. The rapid expansion of resale ecosystems, increasing consumer preference for cost-effective purchasing, and rising sustainability awareness are significantly driving the growth of the Second hand Product Market globally. Market Overview The Second hand Product Market is undergoing aโ€ฆ
Tungsten Market to Reach USD 10.99 Billion by 2032, Driven by Expanding Aerospace, Automotive, and Industrial Applications
Tungsten Market to Reach USD 10.99 Billion by 2032, Driven by Expanding Aerospac โ€ฆ
The Global Tungsten Market is poised for significant expansion over the coming years, with the market size valued at USD 6.41 Billion in 2025 and projected to grow at a CAGR of 8% from 2025 to 2032, reaching nearly USD 10.99 Billion by 2032. Rising industrial demand, technological advancements in material science, and increasing applications in high-performance sectors are collectively driving this steady growth trajectory. Tungsten, recognized for its exceptional hardness,โ€ฆ
System-on-Chip (SoC) Market to Reach USD 391.61 Billion by 2032, Driven by 5G, AI, and IoT Expansion
System-on-Chip (SoC) Market to Reach USD 391.61 Billion by 2032, Driven by 5G, A โ€ฆ
The global System-on-Chip (SoC) Market is poised for significant growth over the forecast period, reflecting the rapid evolution of semiconductor technologies and increasing demand for high-performance, energy-efficient electronic devices. Valued at USD 228.06 Billion in 2025, the market is projected to grow at a CAGR of 8.03% from 2025 to 2032, reaching nearly USD 391.61 Billion by 2032. โ™ฆ Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/33954/ System-on-Chip (SoC) Market Overview Aโ€ฆ

All 5 Releases


More Releases for Japan

Vision Guided Robotic Systems Market Size 2022 - FANUC(Japan), KUKA(Germany), AB โ€ฆ
The Vision Guided Robotic Systems Market research report also provides an in-depth analysis of key players in the market, including their company profiles, business offerings, recent development, market strategies, and critical observation related to the product. The research study provides extensive coverage of the Vision Guided Robotic Systems Market size across all industries and businesses. In addition, it offers detailed insights into market size and growth depending upon various segmentsโ€ฆ
Japan Agriculture Market, Japan Agriculture Industry, Japan Agriculture Livestoc โ€ฆ
The agriculture sector is a very significant sector in Japan. Agriculture sector exists in every part of country, but is especially essential on the northern island of Hokkaido that accounts for approximately 10% of national production. Modern methods such as commercial fertilizers, hybrid seeds, insecticides, and machinery, have been used so efficiently in farming. Japan is the second major agricultural product importer in the world (after the U.S.). Almost allโ€ฆ
Car Navigation ECU Market 2019: Top Key Players are AW Software (Japan), Contine โ€ฆ
Car Navigation ECU Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13844912 Global Car Navigation ECU market 2019 research provides a basic overview of the industryโ€ฆ
Global Car Navigation ECU Market Outlook to 2023 โ€“ AW Software (Japan), Contin โ€ฆ
An automotive navigation system is part of the automobile controls or a third party add-on used to find direction in an automobile and the ECU is the core part control it. Car Navigation typically uses a satellite navigation device to get its position data which is then correlated to a position on a road. According to this study, over the next five years the Car Navigation ECU market will register aโ€ฆ
Global Car Navigation Parts Market Research Report 2019-2025 ย | Global Key Play โ€ฆ
This research report titled โ€œGlobal Car Navigation Parts Marketโ€ Insights, Forecast to 2025 has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Car Navigation Parts Market during the period between 2018 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities inโ€ฆ
Global Automotive 3D Scanning Laser Radar (3D-LiDAR) Market 2019-2025 | Velodyne โ€ฆ
Researchmoz added Most up-to-date research on "Global Automotive 3D Scanning Laser Radar (3D-LiDAR) Market Insights,Forecast to 2025" to its huge collection of research reports. 3D LiDAR uses a pulsed laser to detect distance, velocity and angle with high precision. LiDAR can classify objects, detect lane markings, and may also be used to accurately position an autonomous vehicle relative to a high definition map. 3D LiDAR is prominent, as it is a keyโ€ฆ